000 01815 a2200505 4500
005 20250516032841.0
264 0 _c20110801
008 201108s 0 0 eng d
022 _a1520-4804
024 7 _a10.1021/jm2000882
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMandal, Pijus K
245 0 0 _aPotent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cMay 2011
300 _a3549-63 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aActive Transport, Cell Nucleus
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCell Line, Tumor
650 0 4 _aChemistry, Pharmaceutical
_xmethods
650 0 4 _aDrug Design
650 0 4 _aDrug Screening Assays, Antitumor
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aModels, Chemical
650 0 4 _aPhosphatidylinositol 3-Kinases
_xmetabolism
650 0 4 _aPhosphorylation
650 0 4 _aProdrugs
650 0 4 _aProtein Structure, Tertiary
650 0 4 _aSTAT3 Transcription Factor
_xchemistry
650 0 4 _aSignal Transduction
650 0 4 _asrc Homology Domains
700 1 _aGao, Fengqin
700 1 _aLu, Zhen
700 1 _aRen, Zhiyong
700 1 _aRamesh, Rajagopal
700 1 _aBirtwistle, J Sanderson
700 1 _aKaluarachchi, Kumaralal K
700 1 _aChen, Xiaomin
700 1 _aBast, Robert C
700 1 _aLiao, Warren S
700 1 _aMcMurray, John S
773 0 _tJournal of medicinal chemistry
_gvol. 54
_gno. 10
_gp. 3549-63
856 4 0 _uhttps://doi.org/10.1021/jm2000882
_zAvailable from publisher's website
999 _c20752700
_d20752700